+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antiparasitic Agent"

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 90 Pages
  • Global
From
Veterinary Parasitology. Edition No. 5 - Product Thumbnail Image

Veterinary Parasitology. Edition No. 5

  • Book
  • April 2024
  • 896 Pages
Clinical Guide to Fish Medicine. Edition No. 1 - Product Thumbnail Image

Clinical Guide to Fish Medicine. Edition No. 1

  • Book
  • August 2021
  • 624 Pages
Veterinary Parasitology. Edition No. 4 - Product Thumbnail Image

Veterinary Parasitology. Edition No. 4

  • Book
  • December 2015
  • 1032 Pages
Loading Indicator

The Antiparasitic Agent market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs used to treat parasitic infections. Antiparasitic Agents are used to treat a variety of parasitic infections, including malaria, schistosomiasis, and leishmaniasis. These drugs are typically administered orally, intravenously, or topically, depending on the type of infection. Antiparasitic Agents are often used in combination with other drugs to ensure the most effective treatment. The Antiparasitic Agent market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Other companies, such as Johnson & Johnson, Bayer, and AstraZeneca, also offer Antiparasitic Agents. Show Less Read more